stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Moonlake ImmunotherapeuticsMLTX
$11.472.63%-0.31

Moonlake Immunotherapeutics (MLTX)

Date: 2026-11-02 16:00O: 11.80H: 12.00L: 11.17C: 11.47Vol: 972.0k
Precedente Chiudi:
$11.78
Aprire:
$11.80
Volume 24 ore:
972,019
Volume relativo:
0.48
Capitalizzazione di mercato:
$976.17M
Reddito:
-
Utile/perdita netta:
-$230.32M
Rapporto P/E:
-
EPS:
-$3.53
Flusso di cassa netto:
-$196.04M
1W Prestazione:
-3.86%
1M Prestazione:
+0.53%
6M Prestazione:
-31.44%
1Y Prestazione:
+12.45%
Intervallo 1D:
$0.00$0.00
Intervallo di 1 settimana:
$11.17$12.95
Portata 52W:
$9.46$23.29

Profilo aziendale di Moonlake Immunotherapeutics (MLTX)

Nome
Moonlake Immunotherapeutics
Settore
Healthcare
Industria
Biotechnology
Telefono
41 41 510 8022
Indirizzo
DORFSTRASSE 29, ZUG, Switzerland
Dipendente
130
X
-
Prossima data di guadagno
2026-11-04
Ultimi documenti SEC
SEC
Discussioni di MLTX su X
X

 

Cap. di mercato

 

Reddito

 

Reddito netto

 

Flusso di cassa

 

EPS

 

Moonlake Immunotherapeutics Azioni (MLTX) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2026-03-23AggiornamentoWolfe ResearchUnderperform → Outperform
2026-03-19AggiornamentoRothschild & Co RedburnNeutral → Buy
2026-01-15DowngradeGoldmanNeutral → Sell
2026-01-09AggiornamentoBTIG ResearchNeutral → Buy

Moonlake Immunotherapeutics Azioni (MLTX) Dati Finanziari

PeriodoAndamentoFY 2025FY 2024FY 2023FY 2022
Data di fine periodo2025-12-312024-12-312023-12-312022-12-31
Revenue USD (M)--0.000.00
Research and development USD (M)202.86112.7731.8042.05
Operating expenses USD (M)244.83143.0954.1265.06
Operating income USD (M)-244.83-143.09-54.12-65.06
Income before tax USD (M)-229.71-120.96-43.98-64.47
Income tax expense USD (M)0.610.280.090.04
Net income USD (M)-230.32-121.24-44.08-64.51
Basic EPS USD/shares-3.53-1.89-0.73-1.70
Diluted EPS USD/shares-3.53-1.89-0.73-1.70
Basic weighted shares shares (M)64.4662.8749.1229.36
Diluted weighted shares shares (M)64.4662.8749.1229.36

Moonlake Immunotherapeutics Azioni (MLTX) insider trading

  • Reich KristianJul 27 '26
    Chief Scientific Officer
    Transazione
    Sale
    Costo
    $20.00
    #Azioni
    1,100
    Valore ($)
    22,000
    #Azioni Totale
    2,711,198
  • Reich KristianJul 22 '26
    Chief Scientific Officer
    Transazione
    Sale
    Costo
    $20.00
    #Azioni
    2,448
    Valore ($)
    48,960
    #Azioni Totale
    2,712,298
  • Reich KristianJul 21 '26
    Chief Scientific Officer
    Transazione
    Sale
    Costo
    $20.02
    #Azioni
    50,000
    Valore ($)
    1,001,000
    #Azioni Totale
    2,714,746
  • Reich KristianJul 20 '26
    Chief Scientific Officer
    Transazione
    Sale
    Costo
    $20.09
    #Azioni
    43,700
    Valore ($)
    877,933
    #Azioni Totale
    2,764,746
  • Reich KristianJul 15 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $19.44
    #Azioni
    150,000
    Valore ($)
    2,916,000
    #Azioni Totale
    0
  • Reich KristianJul 15 '26
    Chief Scientific Officer
    Transazione
    Sale
    Costo
    $20.01
    #Azioni
    16,105
    Valore ($)
    322,261
    #Azioni Totale
    2,808,446
  • Chief Executive Officer
    Transazione
    Sale
    Costo
    $20.02
    #Azioni
    68,289
    Valore ($)
    1,367,146
    #Azioni Totale
    2,774,893
  • Chief Executive Officer
    Transazione
    Sale
    Costo
    $20.01
    #Azioni
    33,936
    Valore ($)
    679,059
    #Azioni Totale
    2,843,182
  • Chief Executive Officer
    Transazione
    Sale
    Costo
    $20.03
    #Azioni
    47,775
    Valore ($)
    956,933
    #Azioni Totale
    2,877,118
  • Officer
    Transazione
    Proposed Sale
    Costo
    $20.03
    #Azioni
    150,000
    Valore ($)
    3,004,500
    #Azioni Totale
    0
Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
Reich KristianChief Scientific OfficerJul 27 '26Sale$20.001,10022,0002,711,198
Reich KristianChief Scientific OfficerJul 22 '26Sale$20.002,44848,9602,712,298
Reich KristianChief Scientific OfficerJul 21 '26Sale$20.0250,0001,001,0002,714,746
Reich KristianChief Scientific OfficerJul 20 '26Sale$20.0943,700877,9332,764,746
Reich KristianOfficerJul 15 '26Proposed Sale$19.44150,0002,916,0000
Reich KristianChief Scientific OfficerJul 15 '26Sale$20.0116,105322,2612,808,446
Santos da Silva JorgeChief Executive OfficerJul 10 '26Sale$20.0268,2891,367,1462,774,893
Santos da Silva JorgeChief Executive OfficerJul 09 '26Sale$20.0133,936679,0592,843,182
Santos da Silva JorgeChief Executive OfficerJul 01 '26Sale$20.0347,775956,9332,877,118
Santos da Silva JorgeOfficerJun 30 '26Proposed Sale$20.03150,0003,004,5000

Moonlake Immunotherapeutics Borsa (MLTX) Ultime notizie

Sep 21, 2026
Sep 21, 2026
Sep 12, 2026
Sep 12, 2026
Sep 11, 2026
Sep 11, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 07, 2026
Sep 07, 2026
Sep 01, 2026
Sep 01, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 19, 2026
Aug 19, 2026
Aug 18, 2026
Aug 18, 2026
Aug 16, 2026
Aug 16, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026

Simile a MLTX